mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |